The multifunctionalhuman Parkinson’s diseaseprotein 7(PARK7/DJ1) is an attractive therapeutic target due to its link withearly-onset Parkinson’s disease, upregulation in various cancers,and contribution to chemoresistance. This evidence concerns the gene PARK7 and cancer.